A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Crees Zachary, MD
Washington University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Koln
Cologne, Koln, Germany
- Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases
Budapest, Hungary
- University of Debrecen
Debrecen, Hungary
- Div. Clinicizzata Di Ematologia - Policlinico Vittorio Emanuele
Catania, Italy
- Presidio Ospedaliero Morelli Viale Europa
Reggio Calabria, Italy
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital University Ramon Y Cajal
Madrid, Spain
- Ucla Medical Center
Los Angeles, California, United States
- University of Florida
Gainesville, Florida, United States
- University of Miami
Miami, Florida, United States
- Loyola University Medical Center
Chicago, Illinois, United States
- University of Maryland
Baltimore, Maryland, United States
- Mayo Clinic
Rochester, Minnesota, United States
- the Washington University School of Medicine
St Louis, Missouri, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Md Anderson Cancer Center
Houston Texas, Texas, United States
- Huntsman Cancer Institute in University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Mar 2018
- Primary completion
- 22 Dec 2020
- Completion
- 30 Sept 2029
- Last update posted
- 15 Jan 2026
- Registered enrollment
- 180
- Registry id
- NCT03246529
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.